Mirati Therapeutics, Inc.
MRTX · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$740,867 | -$581,784 | -$357,937 | -$213,256 |
| Dep. & Amort. | $2,929 | $1,781 | $641 | $249 |
| Deferred Tax | $0 | $0 | -$4,879 | $0 |
| Stock-Based Comp. | $186,188 | $113,502 | $85,847 | $55,537 |
| Change in WC | -$10,104 | $65,588 | $16,221 | $13,165 |
| Other Non-Cash | -$8,716 | $12,113 | -$11,424 | -$3,421 |
| Operating Cash Flow | -$570,570 | -$388,800 | -$271,531 | -$147,726 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4,851 | -$9,795 | -$4,367 | -$1,552 |
| Net Acquisitions | -$230,654 | $579,106 | $135,490 | $174,588 |
| Inv. Purchases | -$956,704 | -$1,422,729 | -$662,824 | -$530,228 |
| Inv. Sales/Matur. | $1,187,358 | $843,623 | $527,334 | $355,640 |
| Other Inv. Act. | $230,654 | -$579,106 | -$135,490 | -$174,588 |
| Investing Cash Flow | $225,803 | -$588,901 | -$139,857 | -$176,140 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $155,011 | $474,697 | $1,203,576 | $327,830 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $166,944 | $505,222 | $1,250,714 | $338,028 |
| Financing Cash Flow | $166,944 | $505,222 | $1,250,714 | $338,028 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$177,823 | -$472,479 | $839,326 | $14,162 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $413,703 | $886,182 | $46,856 | $32,694 |
| End Cash | $235,880 | $413,703 | $886,182 | $46,856 |
| Free Cash Flow | -$575,421 | -$398,595 | -$275,898 | -$149,278 |